ConductScience.org, home

Paper17877482

New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma.

Kudo M. Hepatol Res, 2007. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma. Papers, record 17877482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17877482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New sonographic techniques for the diagnosis and treatment of hepatocellular carcinoma.
PubMed
Journal
Hepatol Res
PubMed
Year
2007
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.39
iCite
Revised in PubMed
2020-09-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kudo MMasatoshi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
39583507Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques.Cureus2024https://conductscience.org/library/papers/39583507PubMed
37901198Drug-Off Criteria in Patients with Hepatocellular Carcinoma Who Achieved Clinical Complete Response after Combination Immunotherapy Combined with Locoregional Therapy.Liver Cancer2023https://conductscience.org/library/papers/37901198PubMed
35322130Serum Folate deficiency in HCV related Hepatocellular Carcinoma.Sci Rep2022https://conductscience.org/library/papers/35322130PubMed
32874864The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.J Med Ultrasound2020https://conductscience.org/library/papers/32874864PubMed
32447876The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.Ultrasonography2020https://conductscience.org/library/papers/32447876PubMed
32062622The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment.Intern Med2020https://conductscience.org/library/papers/32062622PubMed
27278700Quantification of tumor vascularity with contrast-enhanced ultrasound for early response of transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of three cases.J Med Ultrason (2001)2012https://conductscience.org/library/papers/27278700PubMed
26694825Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.J Gastroenterol2016https://conductscience.org/library/papers/26694825PubMed
26576571Characterization of the biliary tract by virtual ultrasonography constructed by gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.J Med Ultrason (2001)2015https://conductscience.org/library/papers/26576571PubMed
24764654Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.World J Gastroenterol2014https://conductscience.org/library/papers/24764654PubMed
24133386Advanced ultrasonography technologies to assess the effects of radiofrequency ablation on hepatocellular carcinoma.Radiol Oncol2013https://conductscience.org/library/papers/24133386PubMed
23935709Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case report.Exp Ther Med2013https://conductscience.org/library/papers/23935709PubMed
23837029Arrival time parametric imaging using Sonazoid-enhanced ultrasonography is useful for the detection of spoke-wheel patterns of focal nodular hyperplasia smaller than 3 cm.Exp Ther Med2013https://conductscience.org/library/papers/23837029PubMed
22966329Evaluation of contrast-enhanced ultrasonography using perfluorobutane (Sonazoid(®)) in patients with small hepatocellular carcinoma: comparison with dynamic computed tomography.Oncol Lett2010https://conductscience.org/library/papers/22966329PubMed
22200940Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.J Gastroenterol2012https://conductscience.org/library/papers/22200940PubMed
22174544Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.World J Gastroenterol2011https://conductscience.org/library/papers/22174544PubMed
21160724Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma.World J Radiol2009https://conductscience.org/library/papers/21160724PubMed
21160664Hepatic malignancies: Correlation between sonographic findings and pathological features.World J Radiol2010https://conductscience.org/library/papers/21160664PubMed
19148804Multistep human hepatocarcinogenesis: correlation of imaging with pathology.J Gastroenterol2009https://conductscience.org/library/papers/19148804PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17877482

GET https://conductscience.org/api/papers/v1/17877482/authors